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ABSTRACT 
Neutrophil margination within blood vessels is an early finding during myocardial ischemia and 
can result in myocardial tissue injury. This phenomenon depends on the endothelial expression 
of adhesion molecules, which allow leukocyte extravasation. The hormone relaxin (RLX) was 
found to protect against experimental myocardial injury and to reduce neutrophil extravasation 
into the inflamed tissues. This study addresses the role of RLX in down-regulating endothelial 
adhesiveness to neutrophils and the possible involvement of NO, an anti-adhesive molecule, in 
the mechanism of action of RLX. Lipopolysaccharide (LPS)-primed rat coronary endothelial 
(RCE) cells and neutrophils were co-cultured and their adhesion was quantified in the absence 
and presence of RLX, alone or together with the NO-synthase inhibitor L-NMMA. Inactivated 
RLX was used as control for specificity of the RLX effect. A 24-h incubation of LPS-primed 
RCE cells with RLX (60 and 600 ng/ml) caused a significant reduction of adherent neutrophils 
and of endothelial expression of the adhesion molecules P-selectin and VCAM-1 protein and 
mRNA, evaluated by immunohistochemistry, Western blot, and RT-PCR. These effects of RLX 
were blunted by L-NMMA and were not reproduced by inactivated RLX. These findings suggest 
that RLX has anti-inflammatory properties that could be of benefit in ischemic heart disease. 
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he margination of neutrophils within the vascular compartment is an early finding during 
myocardial ischemia and represents a potential threat to the heart (1, 2). When neutrophils 
encounter endothelial cells in the presence of activating stimuli, a sequence of events is 
initiated that culminates in tissue injury (3). This process prompts neutrophils to adhere to and 
pass through the vascular endothelium, thus reaching the interstitium where they undergo 
activation and release harmful oxygen-derived free radicals and lysosomal enzymes (4). 
Normally, the endothelium inhibits adherence of leukocytes by producing antiadhesive factors, 
such as nitric oxide (NO; 5, 6), and by expressing low levels of endothelial cell adhesion 
molecules (ECAMs), a generic term used to identify different types of surface glycoproteins 
based on their common function (7). Inflammatory mediators generated during myocardial 
ischemia can stimulate the expression of ECAMs. These molecules include early-phase proteins, 
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such as P-selectin, which is held responsible for leukocyte rolling, as well as late-phase proteins, 
such as E-selectin, vascular cell adhesion molecule (VCAM)-1, and intercellular adhesion 
molecule (ICAM)-1, which appear later and are involved in firm adhesion of leukocytes to the 
vascular endothelium that allows leukocyte extravasation into the tissue (6). NO itself can reduce 
the expression of ECAMs, likely by interfering with the activation of the transcription factor NF-
κB or with its binding to the ECAM gene promoters (8, 9). In fact, in vivo studies in laboratory 
mammals have shown that both administration of NO synthesis inhibitors and targeted disruption 
of constitutive NO synthase (NOS) I and III genes cause an increased amount of leukocytes 
adherent to the vascular endothelium (5, 6, 10). 
Recently, evidence has been provided that the peptide hormone relaxin (RLX), a member of the 
insulin/IGF superfamily (11), is a potent stimulator of endogenous NO biosynthesis in cultured 
rat coronary endothelial cells, acting by an overexpression of inducible NOS II (12). 
Experiments in rats subjected to cardiac ischemia/reperfusion have shown that RLX protects 
against myocardial injury, an effect that is accompanied by a marked reduction of neutrophil 
extravasation into the tissue (13). On these grounds, it appears that RLX could exert an anti-
inflammatory effect by interfering with endothelial-leukocyte interactions. The current study was 
designed to test this hypothesis by using an in vitro co-culture model of rat coronary endothelial 
cells and neutrophils, paying special attention to the possible mechanisms of action of RLX at 
the endothelial cell level. 
MATERIALS AND METHODS 
Cells and reagents 
Rat coronary endothelial (RCE) cell cultures were obtained as described previously (14) and 
maintained in M199 medium containing 10% fetal calf serum, 10% newborn calf serum, 250 
IU/ml penicillin, 0.626 µg/ml amphotericin, and 250 µg/ml streptomycin. Unless otherwise 
specified, all the reagents used were from Sigma (St Louis, MO). Sera for cell culture were from 
Gibco BRL (Paisley, Scotland). Cell culture plastic ware was from Falcon (Becton Dickinson 
Europe, Meylan, France). With the isolation procedure used, RCE cell cultures attain a degree of 
purity ranging between 96 and 98%, as evaluated by fluorescent LDL uptake (14). Purified 
porcine RLX (2500 to 3000 U/mg) is a generous gift of O. D. Sherwood. Inactivated RLX 
(iRLX) was obtained by blockade of functional arginine residues by reaction with 
cyclohexanedione followed by dialysis of the unbound reagent against distilled water, according 
to the method of Büllesbach and Schwabe (15). 
Adhesion assay 
RCE cells at the 1st and 2nd culture passage were grown to confluence on round glass coverslips, 
1.4 mm in diameter (Knittel Glaser, Braunschweig, Germany), placed into 24-well multiplates. 
Neutrophil adhesion assay was performed as summarized in Fig. 1. The following sets of RCE 
cell cultures were prepared: i) cells incubated with RLX at the concentrations of 6, 60, and 600 
ng/ml for 24 h (the time point of RLX addition is referred to as h 0); ii) cells incubated with RLX 
(60 ng/ml) for 24 h (h 0) and with the NOS inhibitor NG-monomethyl-L-arginine (L-NMMA, 
10−4 M) for the last 5 h (h 19); iii) cells incubated with iRLX (60 ng/ml) for 24 h in the place of 
authentic RLX; iv) cells treated with L-NMMA alone for 5 h; v) cells not subjected to any 
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treatment, used as controls. Four hours before addition of neutrophils for the adhesion assay (h 
20), the RCE cell cultures were primed with E. coli lipopolysaccharide (LPS, 10 µg/ml) as 
proinflammatory stimulus to induce or enhance the expression of ECAMs (16, 17). LPS was not 
added to a control set of RCE cells, which is referred to as basal culture. Neutrophils were 
isolated from whole blood of rats pretreated with an oral administration of 50 mg warfarin 
(DuPont Pharma, Florence, Italy) in 0.5 ml saline. Blood (10 ml), anticoagulated with 3.8% 
sodium citrate, was collected by cardiac puncture. Neutrophils were obtained by dextran 
sedimentation followed by Ficoll-Paque density gradient centrifugation and hypotonic lysis for 
the removal of residual erythrocytes. Purity of neutrophil preparations ranged between 92 and 
96%, as evaluated by Giemsa stain. The final neutrophil pellet was suspended in M199 medium 
containing 10% fetal calf serum. Cell viability checked by trypan blue exclusion was >95%. 
Neutrophils were primed with LPS (10 µg/ml) for 30 min. at 37°C and then aliquots containing 
~105 cells were added to each RCE cell culture (h 24). Co-cultures were maintained for 15 min. 
at 37°C. After thorough rinsing in phosphate-buffered saline (PBS) to remove unbound 
neutrophils, the co-cultures were fixed in formaldehyde 4% in PBS and counterstained with 
hematoxylin for light microscopic examination. Two independent experiments, each in triplicate, 
were performed. In each sample, the numbers of adherent neutrophils and RCE cells were 
counted in five randomly chosen microscopical fields at a ×200 final magnification (test area: 
22,750 µm2). Values obtained from two different observers were averaged. 
To assess the contribution of different ECAMs to the overall adhesive interactions between LPS-
primed RCE cells and neutrophils, additional experiments with blocking antibodies against 
endothelial ECAMs were performed. RCE cells were grown to confluence on round glass 
coverslips, incubated or not with LPS (10 µg/ml) for 4 h. Thirty minutes before neutrophil 
addition, the cell cultures were treated with polyclonal antibodies against P-selectin (60 µg/ml, 
raised in goat, Santa Cruz Biotechnology, Santa Cruz, CA), VCAM-1 (60 µg/ml, raised in rabbit, 
Santa Cruz), and ICAM-1 (40 µg/ml, raised in mouse, Chemicon, Temecula, CA) added directly 
to the culture medium. Finally, LPS-activated neutrophils were added and co-cultures were 
maintained for 15 min at 37°C. Upon rinsing, fixation, and staining, the numbers of adherent 
neutrophils and RCE cells were counted, as described above. A replicate experiment was 
performed. No experiments with anti-E-selectin antiserum were performed because, in our 
experiment, this adhesion molecule was not expressed by RCE cells, either in basal conditions or 
upon priming with LPS, as revealed by immunocytochemistry, Western blot, and RT-PCR (see 
below). 
Immunocytochemistry for ECAMs 
RCE cells at the 1st and 2nd culture passage were grown to confluence on round glass coverslips, 
1.4 mm in diameter; placed into 24-well multiplates; and incubated with RLX (60 ng/ml), RLX 
and L-NMMA, or iRLX as described above. Basal and LPS-primed RCE cells were the controls. 
Upon fixation in 4% formaldehyde in PBS, the cells were immunostained with polyclonal 
antibodies against P-selectin (1:100, raised in goat, Santa Cruz), E-selectin (1:100, raised in 
rabbit, Santa Cruz), VCAM-1 (1:100, raised in rabbit, Santa Cruz), and ICAM-1 (1:200, raised in 
mouse, Chemicon), following the supplier’s instructions. Immune reaction was revealed by 
biotinylated anti-goat (1:150), anti-rabbit (1:600), or anti-mouse (1:300) secondary antibodies 
and avidin-peroxidase complex (Dako, Glostrup, Denmark) by using 3-3′ diaminobenzidine as 
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chromogen and hematoxylin for nuclear counterstaining. Two different sets of RCE cell cultures 
were immunostained for each adhesion molecule assayed. Observations were performed on at 
least five different microscopical fields at a ×400 final magnification. 
Western blot for ECAMs 
RCE cells at the 1st and 2nd culture passage were grown to confluence into 25 cm2 flasks and 
incubated with RLX (60 ng/ml), or RLX and L -NMMA, as described above. Basal and LPS-
primed RCE cells were the controls. Upon 24 h, cells were processed for Western blot as 
described in a previous article (12). Upon SDS-PAGE (200 V, 1 h) and blotting (150 V, 1 h), 
nitrocellulose membranes were incubated overnight at 4°C under stirring with the same 
antibodies used above (P-selectin, 1:100; VCAM-1, 1:200; E-selectin, 1:100; ICAM-1, 1:1000). 
Immune reaction was revealed by peroxidase-labeled secondary antibodies (Vector, Burlingame, 
CA, 1:10,000) by using the chemiluminescent substrate ECL (Amersham, Milan, Italy) and 
exposure to high-sensitivity photographic film (Biomax ML, Kodak, Rochester, NY). The 
relative intensities of the bands were quantified by densitometric analysis by using Scion Image 
Beta 4.0.2 image analysis program (Scion Corp., Frederick, MD). The values were normalized to 
the corresponding β-actin values and expressed as percent changes of the values of basal RCE 
cells. Values are the mean (± SEM) of three separate experiments. 
Assay for ECAM mRNAs 
Expression levels of mRNA for the ECAMs assayed were measured by semiquantitative reverse 
transcription-PCR (RT-PCR). For this purpose, RCE cells at the 1st and 2nd culture passage were 
grown to confluence into 25 cm2 flasks and incubated with RLX (60 ng/ml) or RLX and L-
NMMA as described above. Basal and LPS-primed RCE cells were the controls. Total cellular 
RNA was extracted by using Trizol Reagent (Gibco-BRL) according to the manufacturer’s 
protocol and quantified spectrophotometrically at a 260 nm wavelength. Then, 100 ng of total 
RNA was reverse-transcribed and amplified with SuperScriptTMOne-StepTM RT-PCR System 
(Invitrogen, Groningen, The Netherlands) in a total volume of 50 µl. After cDNA synthesis for 
30 min at 55°C the samples were pre-denatured for 2 min at 94°C; the first-strand cDNA was 
subjected to 35 cycles of PCR performed at 94°C for 15 s, 58°C for 30 s (P-selectin and VCAM-
1) or 55°C for 30 s (E-selectin and ICAM-1), and 72°C for 1 min; the final extension step was 
performed at 72°C for 5 min. Internal standards for quantification of ECAM cDNAs were 
generated by amplifying β-actin mRNA (annealing temperature: 55°C). The following rat gene-
specific primers were used: P-selectin mRNA (GenBank accession number: L23088), forward 
5′-CTC TGG GGG ACT TCT CCT TC-3′ and reverse 5′-AGG TTG GCA ATG GTT CAC TC-
3′; VCAM-1 mRNA (GenBank accession number: NM 012889), forward 5′- TTG GCT CCT 
GAT GTT TAC CC-3′ and reverse 5′-GCA CCC TCA TGT AGC CTT GT-3′; E-selectin mRNA 
(GenBank accession number: NM138879.1), forward 5′-TGC CCA CGG AGT CAG GAA AT-
3′ and reverse 5′-ACT GCA TTC AAC CTG GGC TG-3′; ICAM-1 mRNA (GenBank accession 
number: NM012967.1), forward 5′-AGG TCT CAG AAG GGG ACC AA-3′ and reverse 5′-
GGT CAG ATT AGG GGC TGG AT-3′; β-actin mRNA (GenBank accession number: NM 
031144), forward 5′-CCA ACC GTG AAA AGA TGA CC-3′ and reverse 5′- AGA GGT CTT 
TAC GGA TGT CA-3′. Expected lengths of amplified fragments were 309, 308, 306, 361, and 
539 base pairs for P-selectin, VCAM-1, E-selectin, ICAM-1, and β-actin, respectively. PCR 
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products were separated by electrophoresis on a 2% agarose gel, and the ethidium bromide-
stained bands were quantified by densitometric analysis by using the Scion Image Beta 4.0.2 
image analysis program. Within the linear range of amplification, the values of P-selectin, 
VCAM-1, and ICAM-1 amplification products were normalized to the corresponding β-actin 
values and expressed as percent changes of the values of basal RCE cells. E-selectin 
amplification product were never detected, despite several experiments at different PCR 
conditions. The reported values are the mean (± SEM) of three separate experiments. 
Statistical analysis 
Statistical comparison of differences between the experimental groups was performed by using 
either one-way ANOVA test followed by Student-Newman-Keuls multiple comparison test or 
Student’s t-test for unpaired values. P ≤ 0.05 was considered significant. Calculations were 
performed by using a GraphPad Prism 2.0 statistical program (GraphPad Software, San Diego, 
CA). 
RESULTS 
By light microscopy, RCE cells primed with LPS showed a marked increase in the amount of 
adherent neutrophils compared with the unprimed cells in basal cultures (Fig. 2A, B). A 24 h 
incubation with RLX caused a reduction of adherent neutrophils, clearly appreciable at 60 and 
600 ng/ml RLX (Fig. 2C, D). The effect of RLX on neutrophil adhesion was blunted by co-
incubation with the NOS inhibitor L-NMMA and was far less evident with iRLX substituted for 
authentic RLX (Fig. 2E, F). Incubation of RCE cells with L-NMMA alone did not substantially 
influence neutrophil adhesion (data not shown). Quantitative analysis confirmed the visual 
observations, for it showed that the number of adherent neutrophils per RCE cell was 
significantly reduced by 60 and 600 ng/ml RLX but not by RLX plus L-NMMA or iRLX. L-
NMMA alone did not significantly change the LPS-induced adhesion of neutrophils to RCE cells 
(Fig. 3). Control adhesion experiments with function-blocking antibodies against P-selectin, 
VCAM-1, and ICAM-1 showed that the tested antisera markedly reduced the number of 
neutrophils adherent to RCE cells, as judged by the neutrophil/RCE cell ratio (basal: 0.15±0.02; 
LPS: 0.43±0.06; LPS + anti-P-selectin: 0.28±0.07; LPS + anti-VCAM-1: 0.28±0.06; LPS + anti-
ICAM-1: 0.22±0.03). 
At a visual examination of immunolabeled RCE cells (Fig. 4), the staining intensity for P-
selectin, VCAM-1 and ICAM-1 appeared enhanced in LPS-primed RCE cells compared with the 
unprimed controls. RLX (60 ng/ml) seemed to decrease the staining intensity for P-selectin and 
VCAM-1 but not for ICAM-1. Of note, RLX plus L-NMMA caused little or no changes and 
iRLX also appeared ineffective (data not shown). Western blot and RT-PCR analysis (Figs. 5, 6) 
fitted well with the immunocytochemical findings. In both cases, quantitative analysis showed 
that RLX caused a clear-cut, significant reduction of the expression of P-selectin and VCAM-1 
protein and mRNA induced by LPS priming in RCE cells. The effect of RLX was abolished by 
the concurrent incubation with L-NMMA. On the other hand, RLX was ineffective in reducing 
ICAM-1 protein and mRNA in LPS-primed RCE cells. Expression of E-selectin was never 
detected in either basal or LPS-primed RCE cells, regardless the assay method used (data not 
shown). 
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DISCUSSION 
The present study provides first experimental evidence that the peptide hormone RLX, acting 
through a NO-dependent mechanism, markedly reduces the adhesiveness of vascular endothelial 
cells to neutrophils upon activation by LPS as proinflammatory stimulus, an effect that is 
apparently exerted by a down-regulation of the expression of some early-phase and late-phase 
ECAMs, namely P-selectin and VCAM-1. The number of neutrophils adhering to RCE cells 
upon LPS priming was significantly reduced by a 24 h incubation with RLX, with a maximal 
effect at the hormone concentration of 60 ng/ml. At these concentration and time of exposure, 
RLX significantly reduced the expression of P-selectin and VCAM-1 mRNA and protein by 
RCE cells induced by a 4 h priming with LPS, as shown by RT-PCR, immunocytochemistry and 
Western blot. Conversely, RLX did not substantially influence ICAM-1 expression, a finding 
that could account for the residual amounts of neutrophils adherent to RCE cells observed in the 
RLX-treated cultures. 
Activation of endothelial cells and leukocytes resulting in reciprocal adhesion and directed 
migration of the latter cells to the inflamed site is an early and crucial event in the inflammatory 
tissue injury. RLX appears to interfere with this phenomenon, thereby exerting anti-
inflammatory effects. Of note, parallel experiments performed by us on isolated human 
neutrophils indicate that RLX, at the same concentrations used in the present study, also reduces 
the activation and chemotaxis of these cells (Masini et al., unpublished data). This novel property 
of RLX may account for at least part of the previously reported beneficial effects of this hormone 
in animal models of inflammation, such as rats subjected to cardiac ischemia and reperfusion and 
sensitized guinea pigs with allergic lung disease due to antigen inhalation, in which a marked 
reduction of leukocytes infiltrating the inflamed tissue was observed upon systemic treatment 
with RLX (13, 18). 
In the present study, the inhibitory effect of RLX on endothelial adhesiveness to neutrophils 
clearly emerges as a specific property of this hormone because it could not be reproduced by 
replacing authentic RLX with iRLX, which is similar to RLX except for its inability to bind to 
RLX receptors (15). The moderate, not statistically significant reduction of neutrophils adherent 
to RCE cells observed upon iRLX treatment is likely to be attributed to a residual biological 
activity of the iRLX preparation, possibly due to incomplete inactivation by cyclohexanedione of 
some RLX molecules. 
Conceivably, the mechanism by which RLX exerts its anti-adhesive effect relies on the 
stimulation of endogenous NO synthesis by RCE cells, which has been shown to depend chiefly 
on the up-regulation of NOS II expression (12). In fact, the present findings show that 
coincubation with the NOS inhibitor L-NMMA blunted the RLX-induced decrease of neutrophil 
adhesion and endothelial expression of P-selectin and VCAM-1. Indeed, NO is known as a 
physiological inhibitor of endothelial-leukocyte interaction (8, 9) and it is worth noting that NO 
can suppress the expression of P-selectin and VCAM-1 by activated endothelial cells (5, 19, 20). 
The present findings may have important functional implications because they provide further 
support to the hypothesis that RLX, which is both secreted and bound specifically by the heart 
(21–23), could have a physiological role as an autocrine cardioprotective factor against the 
detrimental effects of ischemic disease (13). On these grounds, the presence of circulating RLX 
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in women during fertile life may contribute to explain the low incidence of coronary heart 
disease compared with age-matched men and postmenopausal women (24, 25). 
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Figure 1. Schematic diagram of the adhesion experiment. 
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Figure 2. Representative light micrographs of neutrophils adhering to RCE cells in different experimental 
conditions. A) basal; B) LPS activation; C) RLX 60 ng/ml and LPS; D) RLX 600 ng/ml and LPS; E) RLX 60 ng/ml plus 
L-NMMA and LPS; and F) iRLX 60 ng/ml and LPS. Nuclei are counterstained with hematoxylin. Magnification: ×200. 
Bar = 100 µm. 




Figure 3. Bar chart showing the neutrophil/RCE cell ratio in the different experimental conditions. Bars are mean 
± SEM of six separate experiments. Significance of differences (one-way ANOVA): a) P<0.001 vs. basal; b) P<0.001 vs. 
LPS-activated RCE cells; c) P<0.001 vs. RLX 60 ng/ml and LPS; and d) P<0.05 vs. RLX 60 ng/ml and LPS. 




Figure 4. Representative light micrographs of P-selectin, VCAM-1, and ICAM-1 immunocytochemistry in RCE 
cells in different experimental conditions. A) basal; B) LPS activation; C) RLX 60 ng/ml and LPS; and D) RLX 60 
ng/ml plus L-NMMA and LPS. Nuclei are counterstained with hematoxylin. Magnification: ×200. Bar = 100 µm. 
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Figure 5. Analysis of P-selectin, VCAM-1, and ICAM-1 protein expression by Western blot. Lanes: (A) basal; (B) 
LPS activation; (C) RLX 60 ng/ml and LPS; and (D) RLX 60 ng/ml plus L-NMMA and LPS. Columns: dotted, LPS 
activation; blank, RLX; striped, RLX + L-NMMA. The dashed line represents the basal values, assumed as 100%. 
Significance of differences (one-way ANOVA, n=3): (a) P<0.001 vs. basal; (b) P<0.01 vs. LPS; (c) P<0.001 vs. RLX 
alone; (d) P<0.05 vs. basal; (e) P<0.05 vs. LPS; (f) P<0.05 vs. RLX alone; (g) P<0.05 vs. basal; and (h) not significant vs. 
LPS. 
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Figure 6. Analysis of P-selectin, VCAM-1, and ICAM-1 mRNA expression by RT-PCR. Lanes: (A) basal; (B) LPS 
activation; (C) RLX 60 ng/ml and LPS; and (D) RLX 60 ng/ml plus L-NMMA and LPS. Columns: dotted, LPS activation; 
blank, RLX; striped, RLX + L-NMMA. The dashed line represents the basal values, assumed as 100%. Significance of 
differences (one-way ANOVA, n=3): (a) P<0.01 vs. basal; (b) P<0.05 vs. LPS; (c) P<0.05 vs. RLX alone; (d) P<0.001 
vs. basal; (e) P<0.001 vs. LPS; (f) P<0.05 vs. RLX alone; (g) P<0.05 vs. basal; and (h) not significant vs. LPS. 
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